A
Acadia Pharmaceuticals Inc 3911 Sorrento Valley Boulevard Category: Noncommercial Research Organizations |
Company representatives
Thomas Aasen, Finance
Uli Hacksell Phd, Chief Executive Officer
Location Type
Headquarters
Revenue
$40,000,000 - $42,500,000
Employees
27
Years In Business
30
Stock symbol
ACAD
State of incorporation
California
SIC code
873126 (Biotechnology Products & Services)
NAICS code
541711 (Research & Development in Biotechnology)
Rating
Browse U.S. states for Noncommercial Research Organizations
